Exit Readiness Checklist · Speech Therapy Practice

Is Your Speech Therapy Practice Ready to Sell?

Use this step-by-step exit readiness checklist to increase your practice valuation, reduce founder dependency, and position your SLP clinic for a successful acquisition by a qualified buyer — whether that's an SBA-backed clinician, a therapy platform roll-up, or a multi-specialty operator.

Selling a speech therapy practice is a multi-year process that requires far more than finding a buyer. Owner-operators who exit successfully — often at 4x–6x EBITDA — spend 12 to 24 months preparing their financials, reducing personal clinical involvement, securing referral relationships at the practice level, and ensuring compliance with HIPAA, payer contracts, and CMS billing standards. The practices that command premium valuations share a common profile: a team of 3 or more employed SLPs generating revenue independently of the owner, diversified payer and referral sources, clean accrual-based financials, and documented systems that allow day-to-day operations to run without the founder. This checklist walks you through exactly what needs to be done — and when — to get your speech therapy practice to that standard before you go to market.

Get Your Free Speech Therapy Practice Exit Score

5 Things to Do Immediately

  • 1Pull your last 3 years of P&L statements and ask your CPA to identify all owner add-backs — this single step establishes your true EBITDA baseline and is the first number every buyer will ask for.
  • 2Schedule one meeting with your top 3 referral sources this month and begin CC-ing your lead associate SLP on all follow-up communications to start transferring relationship equity to the practice.
  • 3Log into your EHR system and verify that every active clinician has a current HIPAA BAA on file with your vendor — this takes one hour and eliminates a common due diligence flag that delays deals.
  • 4Calculate what percentage of last month's total billable hours were performed by you personally — if it exceeds 35%, that number is your most important exit readiness metric to reduce before listing.
  • 5Download your payer remittance reports for the last 12 months and calculate the percentage of revenue from Medicaid versus private insurance versus direct pay — knowing your payer mix ratio is the first step to improving it.

Phase 1: Financial Clean-Up and Valuation Baseline

18–24 months before listing

Compile 3 years of accrual-based financial statements

highDirectly determines your EBITDA baseline — the foundation of your asking price. Poorly documented financials can reduce your multiple by 1x–2x or kill deals at due diligence.

Buyers and SBA lenders require at least 3 years of profit and loss statements prepared on an accrual basis. If your bookkeeper has been using cash-basis accounting, work with a CPA experienced in healthcare businesses to recast your financials. Clearly document all owner compensation, personal expenses run through the business, and any one-time costs that should be added back to EBITDA.

Separate personal and business expenses

highClean add-back documentation can increase your stated EBITDA by 10–20%, directly lifting your total enterprise value.

Many owner-operator SLPs run personal vehicle expenses, continuing education, and other discretionary costs through the practice. These must be identified, categorized, and added back as owner discretionary expenses before presenting financials to buyers. Buyers and lenders scrutinize these line items closely.

Engage a healthcare-experienced CPA for a quality of earnings preview

highPrevents post-LOI price reductions of 10–25% that commonly result from surprises surfaced during formal due diligence QoE.

Before going to market, have a CPA conduct an informal quality of earnings (QoE) analysis on your practice financials. This surfaces any issues — irregular revenue recognition, Medicaid recoupment reserves, or understated liabilities — that a buyer's QoE firm will find anyway. Fixing these proactively protects your deal price and timeline.

Benchmark your EBITDA margin against industry norms

highImproving EBITDA margin from 15% to 22% on a $2M revenue practice adds roughly $140K in EBITDA, which at a 5x multiple adds $700K to your exit value.

Speech therapy practices that attract premium multiples typically run EBITDA margins of 20–30%. If your margin is below 15%, identify the causes — excessive owner salary, underperforming payer contracts, or bloated overhead — and begin correcting them 18–24 months before listing to show improvement in trailing financials.

Phase 2: Reducing Owner Clinical Dependency

12–18 months before listing

Reduce your personal billable caseload to under 25% of practice revenue

highPractices where the owner performs less than 25% of billable hours routinely trade at 5x–6x EBITDA. Owner-dependent practices rarely exceed 3.5x–4x.

This is the single most important value driver for an SLP practice sale. Buyers — especially PE-backed platforms and SBA-financed operators — will discount heavily or walk away if the owner is generating more than 40% of billable hours. Begin transitioning patients to associate SLPs 12–18 months before listing and document the shift in your revenue attribution by clinician.

Identify and develop a clinical lead or director of operations

highA documented, functioning clinical leadership layer adds credibility to your transition story and protects against earnout risk or buyer hesitation.

Buyers need confidence that operations will continue without you. Identify your strongest associate SLP or office manager and begin transitioning scheduling oversight, clinician supervision, and payer authorization decisions to that person. Document their expanded role formally with a revised job description and compensation structure.

Document all clinical protocols, intake workflows, and scheduling systems

mediumReduces perceived transition risk, which buyers price into their offers. Strong systems documentation supports the upper end of valuation ranges.

Create written SOPs for new patient intake, waitlist management, insurance verification, treatment documentation standards, and discharge planning. Buyers conducting due diligence want evidence that your practice runs on systems — not on you. Well-documented workflows also accelerate post-acquisition integration for platform buyers.

Transition key referral relationships to the practice brand and clinical team

highReferral source durability is a top due diligence focus. Demonstrating practice-level (not owner-level) referral relationships protects against earnout structures and reduces buyer-perceived risk premium.

If your top referral sources — pediatricians, ENT specialists, school district coordinators — call your personal cell and refer to you by name, that's a concentration risk buyers will flag. Over 12–18 months, introduce your associate SLPs to these referral partners, shift communications to a practice email and phone line, and ensure referrals are acknowledged by your team rather than you personally.

Phase 3: Compliance, Credentialing, and Legal Readiness

12–18 months before listing

Conduct an internal billing and coding compliance audit

highUnresolved billing audit exposure can result in representations and warranties escrow holdbacks of 10–15% of deal value or outright deal termination.

Hire a healthcare billing compliance consultant to review your coding practices, payer contract terms, and documentation standards against CMS and state Medicaid guidelines. Unresolved billing irregularities — incorrect CPT codes, insufficient session documentation, or upcoding patterns — are deal-killers if surfaced by a buyer's diligence team. Correct issues proactively and document your remediation.

Update HIPAA policies, BAAs, and EHR documentation standards

highHIPAA compliance gaps create indemnification risk that buyers price into deal structure — often via escrow holdbacks or price reductions of $50K–$150K depending on severity.

Ensure your Notice of Privacy Practices is current, all business associate agreements (BAAs) with your EHR vendor, billing company, and third-party contractors are executed and on file, and your breach response protocol is documented. Buyers will request a HIPAA compliance attestation, and gaps here create liability concerns that delay or derail closings.

Organize and verify all SLP licensure, CEU records, and credentialing files

mediumCredentialing completeness reduces post-close transition friction and protects against clawback provisions tied to clinician credentialing failures.

Compile a complete credentialing file for every employed and contracted SLP including state licensure, ASHA CCC certification, payer panel credentialing status, and CEU completion records. Buyers will verify that all clinicians are properly licensed and credentialed with your key payers. Gaps in credentialing files delay insurance contract assignments post-acquisition.

Review and strengthen employment agreements and non-solicitation provisions

highStrong, enforceable employment agreements with key clinicians are a prerequisite for PE-backed buyers and directly support the 5x–6x multiple range.

Ensure all associate SLPs and support staff have signed employment agreements with clear non-solicitation clauses (protecting patient and referral relationships) and, where appropriate, non-compete provisions enforceable under your state law. Buyers — particularly PE roll-ups — place significant weight on staff retention protection when underwriting their acquisition thesis.

Phase 4: Revenue Quality and Payer Mix Optimization

12–18 months before listing

Analyze and document your payer mix by revenue contribution

highA diversified payer mix with less than 40% Medicaid concentration and meaningful private-pay revenue can shift your multiple from 3.5x–4x to 5x–5.5x.

Prepare a detailed payer mix breakdown showing the percentage of revenue from private insurance, Medicaid, Medicare, school district contracts, and private pay. Buyers will scrutinize this heavily. Practices with heavy Medicaid concentration (above 50%) face higher reimbursement risk discounts. If possible, begin growing private insurance and direct-pay revenue to improve mix quality before going to market.

Secure multi-year renewals on school district contracts and government agreements

highMulti-year school contracts can be treated as contracted recurring revenue, supporting higher EBITDA multiples and reducing buyer risk discount.

If your practice holds service agreements with school districts or government entities, work to renew them with multi-year terms (2–3 years) before listing. These contracts represent recurring, predictable revenue that buyers — especially PE platforms — value highly. A contract that expires within 6 months of closing introduces significant revenue uncertainty.

Document referral source concentration and diversity

mediumReducing referral concentration risk supports cleaner deal structures with fewer earnout contingencies and higher upfront cash at close.

Map your top 10 referral sources by volume and revenue contribution. If any single referral source — one pediatric group, one school district, one ENT practice — accounts for more than 20–25% of new patient volume, develop a plan to diversify. Buyers will flag single-source referral concentration as a key risk and may structure earnouts or price reductions around it.

Evaluate telehealth revenue and document scalability

mediumTelehealth infrastructure expands the buyer universe to include platform acquirers seeking scalable geographic growth and may add a 0.25x–0.5x premium to your multiple.

If your practice offers telehealth services, document the revenue contribution, payer reimbursement rates, and patient utilization by service type. Buyers — especially platform acquirers — view telehealth capability as a scalability asset. If you haven't implemented telehealth, consider doing so 12–18 months before listing to demonstrate the capability and establish a revenue baseline.

Phase 5: Go-to-Market Preparation

3–6 months before listing

Prepare a confidential information memorandum (CIM) with healthcare-specific detail

highA professional CIM positions your practice for competitive offers and signals to buyers that you are a serious, prepared seller — which reduces unnecessary price negotiation.

Work with an M&A advisor or business broker experienced in healthcare to prepare a CIM that tells the story of your practice — clinical specialties, patient demographics, payer mix, team structure, referral relationships, growth opportunities, and financial performance. A well-prepared CIM attracts serious buyers and reduces time-wasting conversations with unqualified parties.

Identify and pre-qualify your target buyer profile

mediumTargeting the right buyer type avoids low offers from unqualified buyers and accelerates the process toward a close at or above your asking price.

Determine whether your ideal buyer is an SBA-financed SLP practitioner, a regional multi-specialty therapy group, or a PE-backed therapy platform. Each buyer type has different valuation expectations, deal structure preferences, and due diligence timelines. Work with your advisor to target outreach appropriately and avoid wasting time with buyers who can't close at your valuation expectations.

Establish a clean data room with organized due diligence materials

highAn organized data room reduces deal fall-through risk from due diligence fatigue and demonstrates the operational professionalism that supports premium valuations.

Create a secure virtual data room containing 3 years of financials, tax returns, payer contracts, staff files, licensure records, HIPAA documentation, referral source data, lease agreements, and EHR system documentation. Having this organized before going to market compresses due diligence timelines from 90 days to 45–60 days and signals operational maturity to buyers.

Consult a healthcare M&A attorney on deal structure and regulatory transfer requirements

highEarly legal preparation prevents costly closing delays and protects you from post-close indemnification claims related to regulatory compliance gaps.

Engage a healthcare transactions attorney to review your corporate structure, assess any CON (certificate of need) requirements in your state, confirm payer contract assignability, and advise on HIPAA-compliant patient record transfer obligations. Many speech therapy practice deals stall at closing due to payer credentialing re-assignment delays or record transfer compliance gaps that were not addressed early.

See What Your Speech Therapy Practice Business Is Worth

Free exit score, valuation range, and personalized action plan — 5 minutes.

Get Free Score

Frequently Asked Questions

How long does it take to sell a speech therapy practice?

Most speech therapy practice sales take 12–24 months from the start of exit preparation to closing. The pre-market preparation phase — cleaning up financials, reducing owner clinical hours, and organizing compliance documentation — typically takes 12–18 months. Once you go to market, finding a qualified buyer, negotiating an LOI, and completing due diligence typically takes another 4–6 months. Practices that go to market unprepared — with owner-dependent revenue or messy financials — often take longer or fail to close at acceptable valuations.

How is a speech therapy practice valued for sale?

Speech therapy practices are typically valued on a multiple of EBITDA (earnings before interest, taxes, depreciation, and amortization), adjusted for owner compensation add-backs. In the lower middle market, multiples typically range from 3.5x to 6x EBITDA depending on practice size, owner independence, payer mix quality, staff stability, and referral source durability. A $2M revenue practice with 22% EBITDA margins and a strong clinical team might generate $440K in adjusted EBITDA, which at a 5x multiple produces a $2.2M enterprise value. Revenue-based multiples are sometimes used for smaller practices but are less reliable than EBITDA multiples.

What is the biggest factor that reduces the value of my speech therapy practice?

Owner dependency is the single biggest value killer in speech therapy practice sales. If you are personally performing more than 35–40% of billable clinical hours and your top referral sources call you by name, buyers will either significantly discount your valuation or structure a large portion of the deal as an earnout contingent on revenue retention post-close. Reducing your personal caseload and transitioning referral relationships to your clinical team before going to market is the highest-return action you can take to increase your exit value.

Will buyers require me to stay on after the sale?

Most buyers of speech therapy practices will require some form of transition involvement from the seller, typically ranging from 3 to 24 months depending on the deal structure. SBA-financed individual buyers often request a 3–6 month clinical and operational transition. PE-backed platform buyers may offer an equity rollover structure where you retain 10–20% ownership and serve as a clinical director or referral development lead for 12–24 months while the platform scales. In earnout structures, your continued involvement may be tied to financial performance milestones. The more owner-independent your practice is at the time of sale, the less transition commitment buyers will require.

Can I sell my speech therapy practice if I have Medicaid patients?

Yes, but Medicaid concentration affects both your valuation and deal structure. Practices with Medicaid representing more than 50% of revenue face scrutiny around reimbursement rate sustainability, administrative burden, and state-level policy risk. Buyers will typically apply a lower EBITDA multiple to Medicaid-heavy practices and may require representations and warranties around billing compliance and audit history. To maximize value, work to grow private insurance and direct-pay revenue before going to market and ensure your Medicaid billing documentation is audit-ready.

Do I need a broker or M&A advisor to sell my speech therapy practice?

While it is technically possible to sell your practice without an advisor, most owner-operators benefit significantly from working with an M&A advisor or healthcare business broker who specializes in lower middle market healthcare transactions. An experienced advisor will help you prepare your CIM, identify qualified buyers (including PE platforms that don't advertise publicly), run a competitive process to maximize your multiple, and guide you through LOI negotiation, due diligence, and closing. Advisor fees typically range from 8–12% of transaction value for practices under $3M, which is usually offset by the higher prices and cleaner deal structures a competitive process produces.

What happens to my patients when I sell the practice?

Patient care continuity is both a legal and ethical obligation in a speech therapy practice sale. Under HIPAA, patients must be notified of the ownership change and given the opportunity to obtain their records or transfer care. Your healthcare transactions attorney will advise on the specific notification requirements in your state. In practice, most buyers have a strong financial incentive to retain your existing patient base, so they will work with you on a thoughtful transition communications plan. The clinical team staying in place — which is why staff retention is so critical in SLP acquisitions — is typically the most effective patient retention strategy.

More Speech Therapy Practice Seller Guides

More Exit Checklists

Start Your Free Exit Assessment

Get your Speech Therapy Practice exit score, estimated valuation, and a step-by-step action plan — free, in 5 minutes.

Start Your Free Exit Assessment

Free forever · No broker needed · Takes 5 minutes